nodes	percent_of_prediction	percent_of_DWPC	metapath
Etoposide—lung cancer—esophageal cancer	0.288	1	CtDrD
Etoposide—GSTT1—esophageal cancer	0.112	0.404	CbGaD
Etoposide—ABCC2—esophageal cancer	0.0647	0.233	CbGaD
Etoposide—GSTT1—Carboplatin—esophageal cancer	0.0643	0.201	CbGbCtD
Etoposide—GSTT1—Cisplatin—esophageal cancer	0.055	0.172	CbGbCtD
Etoposide—PTGS1—esophageal cancer	0.0489	0.177	CbGaD
Etoposide—GSTP1—Carboplatin—esophageal cancer	0.0402	0.126	CbGbCtD
Etoposide—GSTP1—Cisplatin—esophageal cancer	0.0343	0.107	CbGbCtD
Etoposide—ABCC6—Cisplatin—esophageal cancer	0.0316	0.0988	CbGbCtD
Etoposide—PTGS2—esophageal cancer	0.028	0.101	CbGaD
Etoposide—ABCB1—esophageal cancer	0.0238	0.0858	CbGaD
Etoposide—ABCC10—Methotrexate—esophageal cancer	0.0157	0.049	CbGbCtD
Etoposide—ABCC3—Cisplatin—esophageal cancer	0.0152	0.0475	CbGbCtD
Etoposide—ABCC3—Methotrexate—esophageal cancer	0.00985	0.0308	CbGbCtD
Etoposide—ABCC2—Carboplatin—esophageal cancer	0.00807	0.0252	CbGbCtD
Etoposide—ABCG2—Carboplatin—esophageal cancer	0.00729	0.0228	CbGbCtD
Etoposide—ABCC2—Cisplatin—esophageal cancer	0.00689	0.0216	CbGbCtD
Etoposide—PTGS2—Cisplatin—esophageal cancer	0.00681	0.0213	CbGbCtD
Etoposide—ABCG2—Cisplatin—esophageal cancer	0.00623	0.0195	CbGbCtD
Etoposide—ABCC1—Methotrexate—esophageal cancer	0.00605	0.0189	CbGbCtD
Etoposide—ABCC2—Methotrexate—esophageal cancer	0.00447	0.014	CbGbCtD
Etoposide—ABCG2—Methotrexate—esophageal cancer	0.00405	0.0127	CbGbCtD
Etoposide—ABCB1—Cisplatin—esophageal cancer	0.00225	0.00703	CbGbCtD
Etoposide—ABCB1—Methotrexate—esophageal cancer	0.00146	0.00456	CbGbCtD
Etoposide—GSTT1—neck—esophageal cancer	0.00113	0.0702	CbGeAlD
Etoposide—GSTP1—exocrine gland—esophageal cancer	0.000819	0.0507	CbGeAlD
Etoposide—GSTT1—digestive system—esophageal cancer	0.000587	0.0364	CbGeAlD
Etoposide—TOP2B—bronchus—esophageal cancer	0.00056	0.0347	CbGeAlD
Etoposide—TOP2B—smooth muscle tissue—esophageal cancer	0.000548	0.0339	CbGeAlD
Etoposide—GSTP1—neck—esophageal cancer	0.000523	0.0324	CbGeAlD
Etoposide—TOP2B—trachea—esophageal cancer	0.000503	0.0311	CbGeAlD
Etoposide—GSTT1—lung—esophageal cancer	0.00049	0.0304	CbGeAlD
Etoposide—TOP2B—digestive system—esophageal cancer	0.000433	0.0268	CbGeAlD
Etoposide—Nephropathy toxic—Cisplatin—esophageal cancer	0.00043	0.00864	CcSEcCtD
Etoposide—TOP2A—bronchus—esophageal cancer	0.000412	0.0255	CbGeAlD
Etoposide—Febrile neutropenia—Cisplatin—esophageal cancer	0.000411	0.00824	CcSEcCtD
Etoposide—Optic neuritis—Cisplatin—esophageal cancer	0.000402	0.00806	CcSEcCtD
Etoposide—Ascites—Capecitabine—esophageal cancer	0.000401	0.00804	CcSEcCtD
Etoposide—ABCC6—lung—esophageal cancer	0.000398	0.0247	CbGeAlD
Etoposide—Skin necrosis—Methotrexate—esophageal cancer	0.000388	0.00779	CcSEcCtD
Etoposide—TOP2B—lung—esophageal cancer	0.000361	0.0224	CbGeAlD
Etoposide—GSTP1—epithelium—esophageal cancer	0.000356	0.0221	CbGeAlD
Etoposide—GSTP1—bronchus—esophageal cancer	0.000351	0.0217	CbGeAlD
Etoposide—ABCC10—bronchus—esophageal cancer	0.00035	0.0217	CbGeAlD
Etoposide—Neurotoxicity—Methotrexate—esophageal cancer	0.00035	0.00702	CcSEcCtD
Etoposide—UGT1A1—digestive system—esophageal cancer	0.000345	0.0213	CbGeAlD
Etoposide—GSTP1—smooth muscle tissue—esophageal cancer	0.000343	0.0212	CbGeAlD
Etoposide—Mucosal inflammation—Capecitabine—esophageal cancer	0.000329	0.0066	CcSEcCtD
Etoposide—Hepatotoxicity—Cisplatin—esophageal cancer	0.00032	0.00642	CcSEcCtD
Etoposide—Necrosis—Cisplatin—esophageal cancer	0.000315	0.00632	CcSEcCtD
Etoposide—GSTP1—trachea—esophageal cancer	0.000315	0.0195	CbGeAlD
Etoposide—ABCC10—trachea—esophageal cancer	0.000315	0.0195	CbGeAlD
Etoposide—Pulmonary fibrosis—Methotrexate—esophageal cancer	0.000308	0.00619	CcSEcCtD
Etoposide—Febrile neutropenia—Capecitabine—esophageal cancer	0.000303	0.00608	CcSEcCtD
Etoposide—Infection—Carboplatin—esophageal cancer	0.000299	0.00599	CcSEcCtD
Etoposide—Nephropathy—Methotrexate—esophageal cancer	0.000285	0.00572	CcSEcCtD
Etoposide—Extravasation—Cisplatin—esophageal cancer	0.000283	0.00568	CcSEcCtD
Etoposide—Nail disorder—Capecitabine—esophageal cancer	0.000281	0.00564	CcSEcCtD
Etoposide—Interstitial pneumonia—Methotrexate—esophageal cancer	0.000281	0.00563	CcSEcCtD
Etoposide—ABCC3—digestive system—esophageal cancer	0.000272	0.0168	CbGeAlD
Etoposide—Cellulitis—Cisplatin—esophageal cancer	0.000272	0.00545	CcSEcCtD
Etoposide—GSTP1—digestive system—esophageal cancer	0.000271	0.0168	CbGeAlD
Etoposide—ABCC10—digestive system—esophageal cancer	0.000271	0.0168	CbGeAlD
Etoposide—Hyperuricaemia—Cisplatin—esophageal cancer	0.000266	0.00535	CcSEcCtD
Etoposide—TOP2A—lung—esophageal cancer	0.000266	0.0164	CbGeAlD
Etoposide—Ulcer—Cisplatin—esophageal cancer	0.000261	0.00524	CcSEcCtD
Etoposide—Pain—Carboplatin—esophageal cancer	0.000257	0.00516	CcSEcCtD
Etoposide—Blood uric acid increased—Cisplatin—esophageal cancer	0.000252	0.00505	CcSEcCtD
Etoposide—ABCC1—bronchus—esophageal cancer	0.000248	0.0154	CbGeAlD
Etoposide—TOP2B—lymph node—esophageal cancer	0.000247	0.0153	CbGeAlD
Etoposide—Mucosal inflammation—Methotrexate—esophageal cancer	0.000245	0.00492	CcSEcCtD
Etoposide—Body temperature increased—Carboplatin—esophageal cancer	0.000238	0.00477	CcSEcCtD
Etoposide—Skin exfoliation—Cisplatin—esophageal cancer	0.000236	0.00473	CcSEcCtD
Etoposide—Hepatotoxicity—Capecitabine—esophageal cancer	0.000236	0.00473	CcSEcCtD
Etoposide—Neuropathy—Cisplatin—esophageal cancer	0.000232	0.00466	CcSEcCtD
Etoposide—ABCC3—lung—esophageal cancer	0.000227	0.0141	CbGeAlD
Etoposide—Tingling sensation—Capecitabine—esophageal cancer	0.000227	0.00455	CcSEcCtD
Etoposide—GSTP1—lung—esophageal cancer	0.000226	0.014	CbGeAlD
Etoposide—ABCC10—lung—esophageal cancer	0.000226	0.014	CbGeAlD
Etoposide—Febrile neutropenia—Methotrexate—esophageal cancer	0.000225	0.00452	CcSEcCtD
Etoposide—Rigors—Capecitabine—esophageal cancer	0.000223	0.00448	CcSEcCtD
Etoposide—ABCC1—trachea—esophageal cancer	0.000223	0.0138	CbGeAlD
Etoposide—ABCC2—digestive system—esophageal cancer	0.000217	0.0135	CbGeAlD
Etoposide—Nail disorder—Methotrexate—esophageal cancer	0.000209	0.0042	CcSEcCtD
Etoposide—Phlebitis—Cisplatin—esophageal cancer	0.000208	0.00418	CcSEcCtD
Etoposide—Chest discomfort—Capecitabine—esophageal cancer	0.000206	0.00413	CcSEcCtD
Etoposide—Skin discolouration—Capecitabine—esophageal cancer	0.000202	0.00405	CcSEcCtD
Etoposide—Cellulitis—Capecitabine—esophageal cancer	0.0002	0.00402	CcSEcCtD
Etoposide—Cardiac failure congestive—Cisplatin—esophageal cancer	0.000198	0.00397	CcSEcCtD
Etoposide—Ulcer—Capecitabine—esophageal cancer	0.000193	0.00387	CcSEcCtD
Etoposide—Interstitial lung disease—Methotrexate—esophageal cancer	0.000192	0.00384	CcSEcCtD
Etoposide—Cyanosis—Methotrexate—esophageal cancer	0.000192	0.00384	CcSEcCtD
Etoposide—Inflammation—Capecitabine—esophageal cancer	0.000188	0.00377	CcSEcCtD
Etoposide—Anaphylactoid reaction—Cisplatin—esophageal cancer	0.000185	0.00372	CcSEcCtD
Etoposide—Phosphatase alkaline increased—Capecitabine—esophageal cancer	0.000182	0.00366	CcSEcCtD
Etoposide—TOP2A—lymph node—esophageal cancer	0.000182	0.0113	CbGeAlD
Etoposide—Hepatotoxicity—Methotrexate—esophageal cancer	0.000176	0.00352	CcSEcCtD
Etoposide—Candida infection—Capecitabine—esophageal cancer	0.000174	0.00349	CcSEcCtD
Etoposide—Skin exfoliation—Capecitabine—esophageal cancer	0.000174	0.00349	CcSEcCtD
Etoposide—PTGS1—epithelium—esophageal cancer	0.000174	0.0108	CbGeAlD
Etoposide—Necrosis—Methotrexate—esophageal cancer	0.000173	0.00347	CcSEcCtD
Etoposide—Neuropathy—Capecitabine—esophageal cancer	0.000171	0.00343	CcSEcCtD
Etoposide—PTGS1—smooth muscle tissue—esophageal cancer	0.000167	0.0104	CbGeAlD
Etoposide—Oesophagitis—Capecitabine—esophageal cancer	0.000166	0.00334	CcSEcCtD
Etoposide—PTGS2—epithelium—esophageal cancer	0.000166	0.0103	CbGeAlD
Etoposide—Mouth ulceration—Capecitabine—esophageal cancer	0.000165	0.00331	CcSEcCtD
Etoposide—PTGS2—bronchus—esophageal cancer	0.000164	0.0101	CbGeAlD
Etoposide—Cramp muscle—Cisplatin—esophageal cancer	0.000162	0.00324	CcSEcCtD
Etoposide—PTGS2—smooth muscle tissue—esophageal cancer	0.00016	0.00991	CbGeAlD
Etoposide—Apnoea—Methotrexate—esophageal cancer	0.00016	0.00321	CcSEcCtD
Etoposide—ABCC1—lung—esophageal cancer	0.00016	0.0099	CbGeAlD
Etoposide—Sepsis—Capecitabine—esophageal cancer	0.000158	0.00317	CcSEcCtD
Etoposide—Extravasation—Methotrexate—esophageal cancer	0.000155	0.00312	CcSEcCtD
Etoposide—ABCC3—lymph node—esophageal cancer	0.000155	0.00962	CbGeAlD
Etoposide—GSTP1—lymph node—esophageal cancer	0.000155	0.00958	CbGeAlD
Etoposide—ABCC10—lymph node—esophageal cancer	0.000155	0.00958	CbGeAlD
Etoposide—PTGS1—trachea—esophageal cancer	0.000154	0.00952	CbGeAlD
Etoposide—Phlebitis—Capecitabine—esophageal cancer	0.000154	0.00308	CcSEcCtD
Etoposide—CYP1A2—digestive system—esophageal cancer	0.000153	0.00945	CbGeAlD
Etoposide—Blood alkaline phosphatase increased—Capecitabine—esophageal cancer	0.000152	0.00305	CcSEcCtD
Etoposide—Sweating increased—Cisplatin—esophageal cancer	0.000151	0.00303	CcSEcCtD
Etoposide—Skin discolouration—Methotrexate—esophageal cancer	0.00015	0.00301	CcSEcCtD
Etoposide—Swelling—Capecitabine—esophageal cancer	0.00015	0.00301	CcSEcCtD
Etoposide—Pancytopenia—Cisplatin—esophageal cancer	0.000147	0.00295	CcSEcCtD
Etoposide—CYP3A5—digestive system—esophageal cancer	0.000147	0.00911	CbGeAlD
Etoposide—PTGS2—trachea—esophageal cancer	0.000147	0.0091	CbGeAlD
Etoposide—Hyperuricaemia—Methotrexate—esophageal cancer	0.000146	0.00293	CcSEcCtD
Etoposide—Ulcer—Methotrexate—esophageal cancer	0.000143	0.00288	CcSEcCtD
Etoposide—Inflammation—Methotrexate—esophageal cancer	0.00014	0.00281	CcSEcCtD
Etoposide—Blood uric acid increased—Methotrexate—esophageal cancer	0.000138	0.00277	CcSEcCtD
Etoposide—CYP2E1—digestive system—esophageal cancer	0.000137	0.0085	CbGeAlD
Etoposide—Acute coronary syndrome—Cisplatin—esophageal cancer	0.000136	0.00273	CcSEcCtD
Etoposide—Renal failure—Cisplatin—esophageal cancer	0.000136	0.00273	CcSEcCtD
Etoposide—Myocardial infarction—Cisplatin—esophageal cancer	0.000136	0.00272	CcSEcCtD
Etoposide—Neuropathy peripheral—Cisplatin—esophageal cancer	0.000136	0.00272	CcSEcCtD
Etoposide—Cardiac failure—Capecitabine—esophageal cancer	0.000136	0.00272	CcSEcCtD
Etoposide—Stomatitis—Cisplatin—esophageal cancer	0.000135	0.0027	CcSEcCtD
Etoposide—ABCG2—lung—esophageal cancer	0.000132	0.0082	CbGeAlD
Etoposide—PTGS1—digestive system—esophageal cancer	0.000132	0.00819	CbGeAlD
Etoposide—Hepatobiliary disease—Cisplatin—esophageal cancer	0.000131	0.00262	CcSEcCtD
Etoposide—Skin exfoliation—Methotrexate—esophageal cancer	0.00013	0.0026	CcSEcCtD
Etoposide—CYP1A2—lung—esophageal cancer	0.000127	0.00789	CbGeAlD
Etoposide—PTGS2—digestive system—esophageal cancer	0.000126	0.00783	CbGeAlD
Etoposide—Cardiac arrest—Capecitabine—esophageal cancer	0.000126	0.00252	CcSEcCtD
Etoposide—ABCC2—lymph node—esophageal cancer	0.000124	0.00769	CbGeAlD
Etoposide—CYP3A5—lung—esophageal cancer	0.000123	0.00761	CbGeAlD
Etoposide—Mouth ulceration—Methotrexate—esophageal cancer	0.000123	0.00246	CcSEcCtD
Etoposide—Urinary tract disorder—Cisplatin—esophageal cancer	0.000123	0.00246	CcSEcCtD
Etoposide—Urethral disorder—Cisplatin—esophageal cancer	0.000122	0.00244	CcSEcCtD
Etoposide—Toxic epidermal necrolysis—Capecitabine—esophageal cancer	0.000119	0.00239	CcSEcCtD
Etoposide—Sepsis—Methotrexate—esophageal cancer	0.000118	0.00236	CcSEcCtD
Etoposide—Alanine aminotransferase increased—Capecitabine—esophageal cancer	0.000117	0.00234	CcSEcCtD
Etoposide—Eye disorder—Cisplatin—esophageal cancer	0.000116	0.00233	CcSEcCtD
Etoposide—Cardiac disorder—Cisplatin—esophageal cancer	0.000115	0.00231	CcSEcCtD
Etoposide—Flushing—Cisplatin—esophageal cancer	0.000115	0.00231	CcSEcCtD
Etoposide—CYP2E1—lung—esophageal cancer	0.000115	0.0071	CbGeAlD
Etoposide—Dysphagia—Capecitabine—esophageal cancer	0.000114	0.00229	CcSEcCtD
Etoposide—Bronchospasm—Capecitabine—esophageal cancer	0.000112	0.00226	CcSEcCtD
Etoposide—Immune system disorder—Cisplatin—esophageal cancer	0.000112	0.00225	CcSEcCtD
Etoposide—Mediastinal disorder—Cisplatin—esophageal cancer	0.000112	0.00224	CcSEcCtD
Etoposide—Sweating increased—Capecitabine—esophageal cancer	0.000111	0.00223	CcSEcCtD
Etoposide—CYP3A4—digestive system—esophageal cancer	0.00011	0.00684	CbGeAlD
Etoposide—PTGS1—lung—esophageal cancer	0.00011	0.00684	CbGeAlD
Etoposide—Alopecia—Cisplatin—esophageal cancer	0.00011	0.0022	CcSEcCtD
Etoposide—ABCC1—lymph node—esophageal cancer	0.000109	0.00677	CbGeAlD
Etoposide—Pancytopenia—Capecitabine—esophageal cancer	0.000109	0.00218	CcSEcCtD
Etoposide—Neutropenia—Capecitabine—esophageal cancer	0.000107	0.00214	CcSEcCtD
Etoposide—PTGS2—lung—esophageal cancer	0.000106	0.00654	CbGeAlD
Etoposide—Muscle spasms—Cisplatin—esophageal cancer	0.000104	0.00208	CcSEcCtD
Etoposide—ABCB1—epithelium—esophageal cancer	0.000103	0.00636	CbGeAlD
Etoposide—Pneumonia—Capecitabine—esophageal cancer	0.000103	0.00206	CcSEcCtD
Etoposide—Infestation NOS—Capecitabine—esophageal cancer	0.000102	0.00205	CcSEcCtD
Etoposide—Infestation—Capecitabine—esophageal cancer	0.000102	0.00205	CcSEcCtD
Etoposide—Anaphylactoid reaction—Methotrexate—esophageal cancer	0.000102	0.00204	CcSEcCtD
Etoposide—Stevens-Johnson syndrome—Capecitabine—esophageal cancer	0.000101	0.00203	CcSEcCtD
Etoposide—Acute coronary syndrome—Capecitabine—esophageal cancer	0.0001	0.00202	CcSEcCtD
Etoposide—Ill-defined disorder—Cisplatin—esophageal cancer	0.0001	0.00201	CcSEcCtD
Etoposide—Renal failure—Capecitabine—esophageal cancer	0.0001	0.00201	CcSEcCtD
Etoposide—Neuropathy peripheral—Capecitabine—esophageal cancer	9.99e-05	0.002	CcSEcCtD
Etoposide—Myocardial infarction—Capecitabine—esophageal cancer	9.99e-05	0.002	CcSEcCtD
Etoposide—Anaemia—Cisplatin—esophageal cancer	9.99e-05	0.002	CcSEcCtD
Etoposide—Stomatitis—Capecitabine—esophageal cancer	9.94e-05	0.00199	CcSEcCtD
Etoposide—Jaundice—Capecitabine—esophageal cancer	9.94e-05	0.00199	CcSEcCtD
Etoposide—Malaise—Cisplatin—esophageal cancer	9.74e-05	0.00196	CcSEcCtD
Etoposide—Leukopenia—Cisplatin—esophageal cancer	9.67e-05	0.00194	CcSEcCtD
Etoposide—Hepatobiliary disease—Capecitabine—esophageal cancer	9.64e-05	0.00193	CcSEcCtD
Etoposide—Agranulocytosis—Capecitabine—esophageal cancer	9.51e-05	0.00191	CcSEcCtD
Etoposide—Convulsion—Cisplatin—esophageal cancer	9.36e-05	0.00188	CcSEcCtD
Etoposide—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—esophageal cancer	9.14e-05	0.00183	CcSEcCtD
Etoposide—Hypoaesthesia—Capecitabine—esophageal cancer	9.1e-05	0.00183	CcSEcCtD
Etoposide—Discomfort—Cisplatin—esophageal cancer	9.09e-05	0.00182	CcSEcCtD
Etoposide—ABCB1—trachea—esophageal cancer	9.09e-05	0.00563	CbGeAlD
Etoposide—ABCG2—lymph node—esophageal cancer	9.06e-05	0.00561	CbGeAlD
Etoposide—Urinary tract disorder—Capecitabine—esophageal cancer	9.04e-05	0.00181	CcSEcCtD
Etoposide—Urethral disorder—Capecitabine—esophageal cancer	8.97e-05	0.0018	CcSEcCtD
Etoposide—Toxic epidermal necrolysis—Methotrexate—esophageal cancer	8.87e-05	0.00178	CcSEcCtD
Etoposide—Anaphylactic shock—Cisplatin—esophageal cancer	8.82e-05	0.00177	CcSEcCtD
Etoposide—Infection—Cisplatin—esophageal cancer	8.76e-05	0.00176	CcSEcCtD
Etoposide—Erythema multiforme—Capecitabine—esophageal cancer	8.65e-05	0.00174	CcSEcCtD
Etoposide—Thrombocytopenia—Cisplatin—esophageal cancer	8.63e-05	0.00173	CcSEcCtD
Etoposide—Tachycardia—Cisplatin—esophageal cancer	8.61e-05	0.00173	CcSEcCtD
Etoposide—Skin disorder—Cisplatin—esophageal cancer	8.57e-05	0.00172	CcSEcCtD
Etoposide—Eye disorder—Capecitabine—esophageal cancer	8.55e-05	0.00172	CcSEcCtD
Etoposide—Hyperhidrosis—Cisplatin—esophageal cancer	8.53e-05	0.00171	CcSEcCtD
Etoposide—Flushing—Capecitabine—esophageal cancer	8.49e-05	0.0017	CcSEcCtD
Etoposide—Cardiac disorder—Capecitabine—esophageal cancer	8.49e-05	0.0017	CcSEcCtD
Etoposide—Anorexia—Cisplatin—esophageal cancer	8.41e-05	0.00169	CcSEcCtD
Etoposide—Angiopathy—Capecitabine—esophageal cancer	8.3e-05	0.00167	CcSEcCtD
Etoposide—Immune system disorder—Capecitabine—esophageal cancer	8.27e-05	0.00166	CcSEcCtD
Etoposide—Mediastinal disorder—Capecitabine—esophageal cancer	8.25e-05	0.00165	CcSEcCtD
Etoposide—Hypotension—Cisplatin—esophageal cancer	8.24e-05	0.00165	CcSEcCtD
Etoposide—Chills—Capecitabine—esophageal cancer	8.21e-05	0.00165	CcSEcCtD
Etoposide—Alopecia—Capecitabine—esophageal cancer	8.09e-05	0.00162	CcSEcCtD
Etoposide—Pancytopenia—Methotrexate—esophageal cancer	8.08e-05	0.00162	CcSEcCtD
Etoposide—Neutropenia—Methotrexate—esophageal cancer	7.96e-05	0.0016	CcSEcCtD
Etoposide—Paraesthesia—Cisplatin—esophageal cancer	7.92e-05	0.00159	CcSEcCtD
Etoposide—Dyspnoea—Cisplatin—esophageal cancer	7.86e-05	0.00158	CcSEcCtD
Etoposide—ABCB1—digestive system—esophageal cancer	7.82e-05	0.00484	CbGeAlD
Etoposide—Dysgeusia—Capecitabine—esophageal cancer	7.8e-05	0.00156	CcSEcCtD
Etoposide—Back pain—Capecitabine—esophageal cancer	7.7e-05	0.00155	CcSEcCtD
Etoposide—Decreased appetite—Cisplatin—esophageal cancer	7.67e-05	0.00154	CcSEcCtD
Etoposide—Muscle spasms—Capecitabine—esophageal cancer	7.66e-05	0.00154	CcSEcCtD
Etoposide—Pneumonia—Methotrexate—esophageal cancer	7.63e-05	0.00153	CcSEcCtD
Etoposide—Gastrointestinal disorder—Cisplatin—esophageal cancer	7.61e-05	0.00153	CcSEcCtD
Etoposide—Infestation NOS—Methotrexate—esophageal cancer	7.59e-05	0.00152	CcSEcCtD
Etoposide—Infestation—Methotrexate—esophageal cancer	7.59e-05	0.00152	CcSEcCtD
Etoposide—PTGS1—lymph node—esophageal cancer	7.55e-05	0.00468	CbGeAlD
Etoposide—Pain—Cisplatin—esophageal cancer	7.54e-05	0.00151	CcSEcCtD
Etoposide—Stevens-Johnson syndrome—Methotrexate—esophageal cancer	7.52e-05	0.00151	CcSEcCtD
Etoposide—Renal failure—Methotrexate—esophageal cancer	7.46e-05	0.0015	CcSEcCtD
Etoposide—Stomatitis—Methotrexate—esophageal cancer	7.4e-05	0.00148	CcSEcCtD
Etoposide—Ill-defined disorder—Capecitabine—esophageal cancer	7.39e-05	0.00148	CcSEcCtD
Etoposide—Anaemia—Capecitabine—esophageal cancer	7.36e-05	0.00148	CcSEcCtD
Etoposide—Feeling abnormal—Cisplatin—esophageal cancer	7.27e-05	0.00146	CcSEcCtD
Etoposide—PTGS2—lymph node—esophageal cancer	7.22e-05	0.00447	CbGeAlD
Etoposide—Malaise—Capecitabine—esophageal cancer	7.18e-05	0.00144	CcSEcCtD
Etoposide—Hepatobiliary disease—Methotrexate—esophageal cancer	7.18e-05	0.00144	CcSEcCtD
Etoposide—Vertigo—Capecitabine—esophageal cancer	7.16e-05	0.00144	CcSEcCtD
Etoposide—Leukopenia—Capecitabine—esophageal cancer	7.13e-05	0.00143	CcSEcCtD
Etoposide—Agranulocytosis—Methotrexate—esophageal cancer	7.08e-05	0.00142	CcSEcCtD
Etoposide—Loss of consciousness—Capecitabine—esophageal cancer	7e-05	0.0014	CcSEcCtD
Etoposide—Body temperature increased—Cisplatin—esophageal cancer	6.97e-05	0.0014	CcSEcCtD
Etoposide—Cough—Capecitabine—esophageal cancer	6.95e-05	0.00139	CcSEcCtD
Etoposide—Hypertension—Capecitabine—esophageal cancer	6.88e-05	0.00138	CcSEcCtD
Etoposide—Chest pain—Capecitabine—esophageal cancer	6.78e-05	0.00136	CcSEcCtD
Etoposide—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—esophageal cancer	6.73e-05	0.00135	CcSEcCtD
Etoposide—Urinary tract disorder—Methotrexate—esophageal cancer	6.73e-05	0.00135	CcSEcCtD
Etoposide—Discomfort—Capecitabine—esophageal cancer	6.7e-05	0.00134	CcSEcCtD
Etoposide—Urethral disorder—Methotrexate—esophageal cancer	6.68e-05	0.00134	CcSEcCtD
Etoposide—Confusional state—Capecitabine—esophageal cancer	6.55e-05	0.00132	CcSEcCtD
Etoposide—ABCB1—lung—esophageal cancer	6.53e-05	0.00404	CbGeAlD
Etoposide—Hypersensitivity—Cisplatin—esophageal cancer	6.5e-05	0.0013	CcSEcCtD
Etoposide—Infection—Capecitabine—esophageal cancer	6.46e-05	0.0013	CcSEcCtD
Etoposide—Erythema multiforme—Methotrexate—esophageal cancer	6.44e-05	0.00129	CcSEcCtD
Etoposide—Eye disorder—Methotrexate—esophageal cancer	6.37e-05	0.00128	CcSEcCtD
Etoposide—Thrombocytopenia—Capecitabine—esophageal cancer	6.37e-05	0.00128	CcSEcCtD
Etoposide—Tachycardia—Capecitabine—esophageal cancer	6.34e-05	0.00127	CcSEcCtD
Etoposide—Asthenia—Cisplatin—esophageal cancer	6.33e-05	0.00127	CcSEcCtD
Etoposide—Cardiac disorder—Methotrexate—esophageal cancer	6.32e-05	0.00127	CcSEcCtD
Etoposide—Skin disorder—Capecitabine—esophageal cancer	6.31e-05	0.00127	CcSEcCtD
Etoposide—Hyperhidrosis—Capecitabine—esophageal cancer	6.28e-05	0.00126	CcSEcCtD
Etoposide—Anorexia—Capecitabine—esophageal cancer	6.2e-05	0.00124	CcSEcCtD
Etoposide—Angiopathy—Methotrexate—esophageal cancer	6.18e-05	0.00124	CcSEcCtD
Etoposide—Immune system disorder—Methotrexate—esophageal cancer	6.15e-05	0.00123	CcSEcCtD
Etoposide—Mediastinal disorder—Methotrexate—esophageal cancer	6.14e-05	0.00123	CcSEcCtD
Etoposide—Chills—Methotrexate—esophageal cancer	6.11e-05	0.00123	CcSEcCtD
Etoposide—Hypotension—Capecitabine—esophageal cancer	6.07e-05	0.00122	CcSEcCtD
Etoposide—Diarrhoea—Cisplatin—esophageal cancer	6.03e-05	0.00121	CcSEcCtD
Etoposide—Alopecia—Methotrexate—esophageal cancer	6.02e-05	0.00121	CcSEcCtD
Etoposide—Paraesthesia—Capecitabine—esophageal cancer	5.84e-05	0.00117	CcSEcCtD
Etoposide—Dysgeusia—Methotrexate—esophageal cancer	5.81e-05	0.00117	CcSEcCtD
Etoposide—Dyspnoea—Capecitabine—esophageal cancer	5.8e-05	0.00116	CcSEcCtD
Etoposide—Back pain—Methotrexate—esophageal cancer	5.74e-05	0.00115	CcSEcCtD
Etoposide—Decreased appetite—Capecitabine—esophageal cancer	5.65e-05	0.00113	CcSEcCtD
Etoposide—Gastrointestinal disorder—Capecitabine—esophageal cancer	5.61e-05	0.00113	CcSEcCtD
Etoposide—Vomiting—Cisplatin—esophageal cancer	5.61e-05	0.00112	CcSEcCtD
Etoposide—Fatigue—Capecitabine—esophageal cancer	5.6e-05	0.00112	CcSEcCtD
Etoposide—Rash—Cisplatin—esophageal cancer	5.56e-05	0.00112	CcSEcCtD
Etoposide—Pain—Capecitabine—esophageal cancer	5.56e-05	0.00112	CcSEcCtD
Etoposide—Constipation—Capecitabine—esophageal cancer	5.56e-05	0.00112	CcSEcCtD
Etoposide—Dermatitis—Cisplatin—esophageal cancer	5.56e-05	0.00111	CcSEcCtD
Etoposide—Ill-defined disorder—Methotrexate—esophageal cancer	5.5e-05	0.0011	CcSEcCtD
Etoposide—Anaemia—Methotrexate—esophageal cancer	5.48e-05	0.0011	CcSEcCtD
Etoposide—Feeling abnormal—Capecitabine—esophageal cancer	5.36e-05	0.00107	CcSEcCtD
Etoposide—Malaise—Methotrexate—esophageal cancer	5.35e-05	0.00107	CcSEcCtD
Etoposide—Vertigo—Methotrexate—esophageal cancer	5.33e-05	0.00107	CcSEcCtD
Etoposide—Gastrointestinal pain—Capecitabine—esophageal cancer	5.32e-05	0.00107	CcSEcCtD
Etoposide—Leukopenia—Methotrexate—esophageal cancer	5.31e-05	0.00106	CcSEcCtD
Etoposide—Nausea—Cisplatin—esophageal cancer	5.24e-05	0.00105	CcSEcCtD
Etoposide—Cough—Methotrexate—esophageal cancer	5.17e-05	0.00104	CcSEcCtD
Etoposide—Urticaria—Capecitabine—esophageal cancer	5.16e-05	0.00104	CcSEcCtD
Etoposide—Abdominal pain—Capecitabine—esophageal cancer	5.14e-05	0.00103	CcSEcCtD
Etoposide—Body temperature increased—Capecitabine—esophageal cancer	5.14e-05	0.00103	CcSEcCtD
Etoposide—Convulsion—Methotrexate—esophageal cancer	5.14e-05	0.00103	CcSEcCtD
Etoposide—Chest pain—Methotrexate—esophageal cancer	5.05e-05	0.00101	CcSEcCtD
Etoposide—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—esophageal cancer	5.01e-05	0.00101	CcSEcCtD
Etoposide—Discomfort—Methotrexate—esophageal cancer	4.99e-05	0.001	CcSEcCtD
Etoposide—Confusional state—Methotrexate—esophageal cancer	4.88e-05	0.000979	CcSEcCtD
Etoposide—Anaphylactic shock—Methotrexate—esophageal cancer	4.84e-05	0.000971	CcSEcCtD
Etoposide—Infection—Methotrexate—esophageal cancer	4.81e-05	0.000965	CcSEcCtD
Etoposide—Hypersensitivity—Capecitabine—esophageal cancer	4.79e-05	0.000961	CcSEcCtD
Etoposide—Thrombocytopenia—Methotrexate—esophageal cancer	4.74e-05	0.000951	CcSEcCtD
Etoposide—Skin disorder—Methotrexate—esophageal cancer	4.7e-05	0.000943	CcSEcCtD
Etoposide—Hyperhidrosis—Methotrexate—esophageal cancer	4.68e-05	0.000939	CcSEcCtD
Etoposide—Asthenia—Capecitabine—esophageal cancer	4.66e-05	0.000936	CcSEcCtD
Etoposide—Anorexia—Methotrexate—esophageal cancer	4.61e-05	0.000926	CcSEcCtD
Etoposide—Pruritus—Capecitabine—esophageal cancer	4.6e-05	0.000923	CcSEcCtD
Etoposide—Hypotension—Methotrexate—esophageal cancer	4.52e-05	0.000907	CcSEcCtD
Etoposide—ABCB1—lymph node—esophageal cancer	4.47e-05	0.00277	CbGeAlD
Etoposide—Diarrhoea—Capecitabine—esophageal cancer	4.45e-05	0.000892	CcSEcCtD
Etoposide—Paraesthesia—Methotrexate—esophageal cancer	4.35e-05	0.000872	CcSEcCtD
Etoposide—Dyspnoea—Methotrexate—esophageal cancer	4.31e-05	0.000866	CcSEcCtD
Etoposide—Somnolence—Methotrexate—esophageal cancer	4.3e-05	0.000863	CcSEcCtD
Etoposide—Dizziness—Capecitabine—esophageal cancer	4.3e-05	0.000862	CcSEcCtD
Etoposide—Decreased appetite—Methotrexate—esophageal cancer	4.21e-05	0.000844	CcSEcCtD
Etoposide—Gastrointestinal disorder—Methotrexate—esophageal cancer	4.18e-05	0.000838	CcSEcCtD
Etoposide—Fatigue—Methotrexate—esophageal cancer	4.17e-05	0.000837	CcSEcCtD
Etoposide—Pain—Methotrexate—esophageal cancer	4.14e-05	0.00083	CcSEcCtD
Etoposide—Vomiting—Capecitabine—esophageal cancer	4.13e-05	0.000829	CcSEcCtD
Etoposide—Rash—Capecitabine—esophageal cancer	4.1e-05	0.000822	CcSEcCtD
Etoposide—Dermatitis—Capecitabine—esophageal cancer	4.1e-05	0.000822	CcSEcCtD
Etoposide—Headache—Capecitabine—esophageal cancer	4.07e-05	0.000817	CcSEcCtD
Etoposide—Feeling abnormal—Methotrexate—esophageal cancer	3.99e-05	0.0008	CcSEcCtD
Etoposide—Gastrointestinal pain—Methotrexate—esophageal cancer	3.96e-05	0.000794	CcSEcCtD
Etoposide—Nausea—Capecitabine—esophageal cancer	3.86e-05	0.000775	CcSEcCtD
Etoposide—Urticaria—Methotrexate—esophageal cancer	3.84e-05	0.000771	CcSEcCtD
Etoposide—Abdominal pain—Methotrexate—esophageal cancer	3.83e-05	0.000768	CcSEcCtD
Etoposide—Body temperature increased—Methotrexate—esophageal cancer	3.83e-05	0.000768	CcSEcCtD
Etoposide—Hypersensitivity—Methotrexate—esophageal cancer	3.57e-05	0.000715	CcSEcCtD
Etoposide—Asthenia—Methotrexate—esophageal cancer	3.47e-05	0.000697	CcSEcCtD
Etoposide—Pruritus—Methotrexate—esophageal cancer	3.42e-05	0.000687	CcSEcCtD
Etoposide—Diarrhoea—Methotrexate—esophageal cancer	3.31e-05	0.000664	CcSEcCtD
Etoposide—Dizziness—Methotrexate—esophageal cancer	3.2e-05	0.000642	CcSEcCtD
Etoposide—Vomiting—Methotrexate—esophageal cancer	3.08e-05	0.000617	CcSEcCtD
Etoposide—Rash—Methotrexate—esophageal cancer	3.05e-05	0.000612	CcSEcCtD
Etoposide—Dermatitis—Methotrexate—esophageal cancer	3.05e-05	0.000612	CcSEcCtD
Etoposide—Headache—Methotrexate—esophageal cancer	3.03e-05	0.000608	CcSEcCtD
Etoposide—Nausea—Methotrexate—esophageal cancer	2.87e-05	0.000577	CcSEcCtD
Etoposide—TOP2A—Cell Cycle—TP53—esophageal cancer	3.83e-06	7.73e-05	CbGpPWpGaD
Etoposide—PTGS2—Disease—CALR—esophageal cancer	3.78e-06	7.64e-05	CbGpPWpGaD
Etoposide—ABCB1—Metabolism—ADH1B—esophageal cancer	3.78e-06	7.64e-05	CbGpPWpGaD
Etoposide—UGT1A1—Metabolism—HMOX1—esophageal cancer	3.77e-06	7.63e-05	CbGpPWpGaD
Etoposide—CYP2E1—Metabolism—GNG7—esophageal cancer	3.77e-06	7.62e-05	CbGpPWpGaD
Etoposide—CYP3A5—Metabolism—GNG7—esophageal cancer	3.77e-06	7.61e-05	CbGpPWpGaD
Etoposide—PTGS2—Metabolism—ALDH2—esophageal cancer	3.76e-06	7.59e-05	CbGpPWpGaD
Etoposide—CYP2C8—Metabolism—GSTO1—esophageal cancer	3.75e-06	7.58e-05	CbGpPWpGaD
Etoposide—CYP2C8—Metabolism—TPI1—esophageal cancer	3.75e-06	7.58e-05	CbGpPWpGaD
Etoposide—ABCG2—Metabolism—CYP1B1—esophageal cancer	3.73e-06	7.54e-05	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism—CA2—esophageal cancer	3.7e-06	7.48e-05	CbGpPWpGaD
Etoposide—ABCB1—Transmembrane transport of small molecules—HMOX1—esophageal cancer	3.7e-06	7.47e-05	CbGpPWpGaD
Etoposide—CYP3A4—Metabolism—SLC52A3—esophageal cancer	3.67e-06	7.42e-05	CbGpPWpGaD
Etoposide—CYP3A4—Metabolism—BLVRB—esophageal cancer	3.67e-06	7.42e-05	CbGpPWpGaD
Etoposide—PTGS2—Disease—FBXW7—esophageal cancer	3.66e-06	7.39e-05	CbGpPWpGaD
Etoposide—ABCC1—Metabolism—HMOX1—esophageal cancer	3.64e-06	7.35e-05	CbGpPWpGaD
Etoposide—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—esophageal cancer	3.63e-06	7.33e-05	CbGpPWpGaD
Etoposide—UGT1A1—Metabolism—ABCB1—esophageal cancer	3.62e-06	7.32e-05	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism of lipids and lipoproteins—CYP1B1—esophageal cancer	3.62e-06	7.31e-05	CbGpPWpGaD
Etoposide—ABCB1—Metabolism—TYMP—esophageal cancer	3.61e-06	7.3e-05	CbGpPWpGaD
Etoposide—CYP2C8—Metabolism—ALDOB—esophageal cancer	3.6e-06	7.26e-05	CbGpPWpGaD
Etoposide—PTGS1—Metabolism—CYP1B1—esophageal cancer	3.59e-06	7.25e-05	CbGpPWpGaD
Etoposide—PTGS2—Metabolism—GSTT1—esophageal cancer	3.57e-06	7.22e-05	CbGpPWpGaD
Etoposide—ABCC1—Metabolism of lipids and lipoproteins—EP300—esophageal cancer	3.57e-06	7.21e-05	CbGpPWpGaD
Etoposide—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—esophageal cancer	3.55e-06	7.16e-05	CbGpPWpGaD
Etoposide—CYP2E1—Metabolism—ALDH2—esophageal cancer	3.54e-06	7.14e-05	CbGpPWpGaD
Etoposide—PTGS2—Metabolism—CYP2A6—esophageal cancer	3.53e-06	7.14e-05	CbGpPWpGaD
Etoposide—CYP3A5—Metabolism—ALDH2—esophageal cancer	3.53e-06	7.13e-05	CbGpPWpGaD
Etoposide—PTGS2—Metabolism of lipids and lipoproteins—CREBBP—esophageal cancer	3.52e-06	7.11e-05	CbGpPWpGaD
Etoposide—ABCB1—Metabolism—CYP26A1—esophageal cancer	3.51e-06	7.1e-05	CbGpPWpGaD
Etoposide—ABCG2—Metabolism—CYP19A1—esophageal cancer	3.51e-06	7.09e-05	CbGpPWpGaD
Etoposide—ABCC1—Metabolism—ABCB1—esophageal cancer	3.49e-06	7.06e-05	CbGpPWpGaD
Etoposide—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—esophageal cancer	3.47e-06	7e-05	CbGpPWpGaD
Etoposide—CYP2C8—Metabolism—GAPDH—esophageal cancer	3.46e-06	6.99e-05	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism—ADH7—esophageal cancer	3.44e-06	6.95e-05	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism—PLCE1—esophageal cancer	3.44e-06	6.95e-05	CbGpPWpGaD
Etoposide—CYP2C8—Metabolism—CRABP1—esophageal cancer	3.43e-06	6.93e-05	CbGpPWpGaD
Etoposide—ABCB1—Metabolism—ALOX15—esophageal cancer	3.42e-06	6.92e-05	CbGpPWpGaD
Etoposide—ABCC1—Disease—HIF1A—esophageal cancer	3.41e-06	6.9e-05	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism of lipids and lipoproteins—CYP19A1—esophageal cancer	3.4e-06	6.87e-05	CbGpPWpGaD
Etoposide—PTGS1—Metabolism—CYP19A1—esophageal cancer	3.37e-06	6.81e-05	CbGpPWpGaD
Etoposide—ABCC3—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	3.37e-06	6.81e-05	CbGpPWpGaD
Etoposide—CYP2E1—Metabolism—GSTT1—esophageal cancer	3.36e-06	6.8e-05	CbGpPWpGaD
Etoposide—CYP3A5—Metabolism—GSTT1—esophageal cancer	3.36e-06	6.78e-05	CbGpPWpGaD
Etoposide—PTGS2—Metabolism—ENO1—esophageal cancer	3.35e-06	6.76e-05	CbGpPWpGaD
Etoposide—PTGS2—Metabolism—PTGS1—esophageal cancer	3.35e-06	6.76e-05	CbGpPWpGaD
Etoposide—CYP2E1—Metabolism—CYP2A6—esophageal cancer	3.33e-06	6.72e-05	CbGpPWpGaD
Etoposide—CYP3A5—Metabolism—CYP2A6—esophageal cancer	3.32e-06	6.7e-05	CbGpPWpGaD
Etoposide—PTGS2—Metabolism—PSME2—esophageal cancer	3.3e-06	6.67e-05	CbGpPWpGaD
Etoposide—PTGS2—Metabolism—PSME1—esophageal cancer	3.3e-06	6.67e-05	CbGpPWpGaD
Etoposide—GSTP1—Metabolism—EP300—esophageal cancer	3.29e-06	6.64e-05	CbGpPWpGaD
Etoposide—ABCB1—Metabolism—TPI1—esophageal cancer	3.27e-06	6.6e-05	CbGpPWpGaD
Etoposide—ABCB1—Metabolism—GSTO1—esophageal cancer	3.27e-06	6.6e-05	CbGpPWpGaD
Etoposide—CYP2C8—Metabolism—GNG7—esophageal cancer	3.26e-06	6.59e-05	CbGpPWpGaD
Etoposide—ABCG2—Metabolism—HMOX1—esophageal cancer	3.2e-06	6.47e-05	CbGpPWpGaD
Etoposide—CYP2E1—Metabolism—PTGS1—esophageal cancer	3.15e-06	6.37e-05	CbGpPWpGaD
Etoposide—CYP2E1—Metabolism—ENO1—esophageal cancer	3.15e-06	6.37e-05	CbGpPWpGaD
Etoposide—CYP3A5—Metabolism—PTGS1—esophageal cancer	3.15e-06	6.35e-05	CbGpPWpGaD
Etoposide—CYP3A5—Metabolism—ENO1—esophageal cancer	3.15e-06	6.35e-05	CbGpPWpGaD
Etoposide—ABCB1—Metabolism—ALDOB—esophageal cancer	3.13e-06	6.33e-05	CbGpPWpGaD
Etoposide—CYP3A4—Metabolism—SLC10A2—esophageal cancer	3.12e-06	6.31e-05	CbGpPWpGaD
Etoposide—CYP3A4—Metabolism—CA1—esophageal cancer	3.12e-06	6.31e-05	CbGpPWpGaD
Etoposide—CYP2E1—Metabolism—PSME1—esophageal cancer	3.11e-06	6.27e-05	CbGpPWpGaD
Etoposide—CYP2E1—Metabolism—PSME2—esophageal cancer	3.11e-06	6.27e-05	CbGpPWpGaD
Etoposide—ABCC1—Disease—NOS2—esophageal cancer	3.11e-06	6.27e-05	CbGpPWpGaD
Etoposide—CYP3A5—Metabolism—PSME1—esophageal cancer	3.1e-06	6.26e-05	CbGpPWpGaD
Etoposide—CYP3A5—Metabolism—PSME2—esophageal cancer	3.1e-06	6.26e-05	CbGpPWpGaD
Etoposide—PTGS1—Metabolism—HMOX1—esophageal cancer	3.08e-06	6.22e-05	CbGpPWpGaD
Etoposide—ABCC1—Disease—NOTCH1—esophageal cancer	3.08e-06	6.21e-05	CbGpPWpGaD
Etoposide—ABCG2—Metabolism—ABCB1—esophageal cancer	3.07e-06	6.21e-05	CbGpPWpGaD
Etoposide—CYP2C8—Metabolism—ALDH2—esophageal cancer	3.06e-06	6.18e-05	CbGpPWpGaD
Etoposide—PTGS1—Metabolism of lipids and lipoproteins—EP300—esophageal cancer	3.02e-06	6.1e-05	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism—ADH1B—esophageal cancer	3.02e-06	6.1e-05	CbGpPWpGaD
Etoposide—ABCB1—Metabolism—GAPDH—esophageal cancer	3.02e-06	6.09e-05	CbGpPWpGaD
Etoposide—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—esophageal cancer	3.01e-06	6.08e-05	CbGpPWpGaD
Etoposide—ABCB1—Metabolism—CRABP1—esophageal cancer	2.99e-06	6.04e-05	CbGpPWpGaD
Etoposide—ABCC3—Metabolism—CREBBP—esophageal cancer	2.98e-06	6.02e-05	CbGpPWpGaD
Etoposide—PTGS2—Disease—TGFBR2—esophageal cancer	2.96e-06	5.97e-05	CbGpPWpGaD
Etoposide—PTGS1—Metabolism—ABCB1—esophageal cancer	2.95e-06	5.97e-05	CbGpPWpGaD
Etoposide—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—esophageal cancer	2.91e-06	5.88e-05	CbGpPWpGaD
Etoposide—CYP2C8—Metabolism—GSTT1—esophageal cancer	2.91e-06	5.87e-05	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism—TYMP—esophageal cancer	2.88e-06	5.83e-05	CbGpPWpGaD
Etoposide—CYP2C8—Metabolism—CYP2A6—esophageal cancer	2.87e-06	5.81e-05	CbGpPWpGaD
Etoposide—CYP2C8—Metabolism of lipids and lipoproteins—CREBBP—esophageal cancer	2.86e-06	5.78e-05	CbGpPWpGaD
Etoposide—CYP3A4—Metabolism—CA2—esophageal cancer	2.86e-06	5.77e-05	CbGpPWpGaD
Etoposide—PTGS2—Metabolism—CYP1B1—esophageal cancer	2.85e-06	5.75e-05	CbGpPWpGaD
Etoposide—ABCB1—Metabolism—GNG7—esophageal cancer	2.84e-06	5.74e-05	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism—CYP26A1—esophageal cancer	2.81e-06	5.67e-05	CbGpPWpGaD
Etoposide—PTGS2—Disease—SMAD4—esophageal cancer	2.8e-06	5.66e-05	CbGpPWpGaD
Etoposide—ABCC1—Disease—CREBBP—esophageal cancer	2.79e-06	5.63e-05	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism—ALOX15—esophageal cancer	2.73e-06	5.52e-05	CbGpPWpGaD
Etoposide—CYP2C8—Metabolism—PTGS1—esophageal cancer	2.72e-06	5.5e-05	CbGpPWpGaD
Etoposide—CYP2C8—Metabolism—ENO1—esophageal cancer	2.72e-06	5.5e-05	CbGpPWpGaD
Etoposide—CYP2C8—Metabolism—PSME1—esophageal cancer	2.68e-06	5.42e-05	CbGpPWpGaD
Etoposide—CYP2C8—Metabolism—PSME2—esophageal cancer	2.68e-06	5.42e-05	CbGpPWpGaD
Etoposide—CYP2E1—Metabolism—CYP1B1—esophageal cancer	2.68e-06	5.41e-05	CbGpPWpGaD
Etoposide—PTGS2—Metabolism—CYP19A1—esophageal cancer	2.68e-06	5.41e-05	CbGpPWpGaD
Etoposide—CYP3A5—Metabolism—CYP1B1—esophageal cancer	2.67e-06	5.4e-05	CbGpPWpGaD
Etoposide—ABCC3—Metabolism—NOS3—esophageal cancer	2.67e-06	5.39e-05	CbGpPWpGaD
Etoposide—ABCB1—Metabolism—ALDH2—esophageal cancer	2.66e-06	5.38e-05	CbGpPWpGaD
Etoposide—CYP3A4—Metabolism—PLCE1—esophageal cancer	2.66e-06	5.36e-05	CbGpPWpGaD
Etoposide—CYP3A4—Metabolism—ADH7—esophageal cancer	2.66e-06	5.36e-05	CbGpPWpGaD
Etoposide—ABCC1—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	2.64e-06	5.34e-05	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism—TPI1—esophageal cancer	2.61e-06	5.27e-05	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism—GSTO1—esophageal cancer	2.61e-06	5.27e-05	CbGpPWpGaD
Etoposide—ABCB1—Metabolism—GSTT1—esophageal cancer	2.53e-06	5.12e-05	CbGpPWpGaD
Etoposide—CYP2E1—Metabolism—CYP19A1—esophageal cancer	2.52e-06	5.09e-05	CbGpPWpGaD
Etoposide—CYP3A5—Metabolism—CYP19A1—esophageal cancer	2.51e-06	5.08e-05	CbGpPWpGaD
Etoposide—ABCB1—Metabolism—CYP2A6—esophageal cancer	2.5e-06	5.06e-05	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism—ALDOB—esophageal cancer	2.5e-06	5.05e-05	CbGpPWpGaD
Etoposide—ABCC1—Disease—NOS3—esophageal cancer	2.5e-06	5.04e-05	CbGpPWpGaD
Etoposide—PTGS2—Metabolism—HMOX1—esophageal cancer	2.44e-06	4.93e-05	CbGpPWpGaD
Etoposide—ABCC3—Metabolism—PTGS2—esophageal cancer	2.44e-06	4.93e-05	CbGpPWpGaD
Etoposide—GSTP1—Metabolism—PIK3CA—esophageal cancer	2.43e-06	4.91e-05	CbGpPWpGaD
Etoposide—UGT1A1—Metabolism—CREBBP—esophageal cancer	2.42e-06	4.89e-05	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism—GAPDH—esophageal cancer	2.41e-06	4.86e-05	CbGpPWpGaD
Etoposide—PTGS2—Metabolism of lipids and lipoproteins—EP300—esophageal cancer	2.4e-06	4.84e-05	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism—CRABP1—esophageal cancer	2.39e-06	4.82e-05	CbGpPWpGaD
Etoposide—ABCB1—Metabolism—PTGS1—esophageal cancer	2.37e-06	4.79e-05	CbGpPWpGaD
Etoposide—ABCB1—Metabolism—ENO1—esophageal cancer	2.37e-06	4.79e-05	CbGpPWpGaD
Etoposide—ABCB1—Transmembrane transport of small molecules—CREBBP—esophageal cancer	2.37e-06	4.79e-05	CbGpPWpGaD
Etoposide—PTGS2—Metabolism—ABCB1—esophageal cancer	2.34e-06	4.74e-05	CbGpPWpGaD
Etoposide—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—esophageal cancer	2.34e-06	4.74e-05	CbGpPWpGaD
Etoposide—ABCB1—Metabolism—PSME2—esophageal cancer	2.34e-06	4.72e-05	CbGpPWpGaD
Etoposide—ABCB1—Metabolism—PSME1—esophageal cancer	2.34e-06	4.72e-05	CbGpPWpGaD
Etoposide—ABCC1—Metabolism—CREBBP—esophageal cancer	2.34e-06	4.72e-05	CbGpPWpGaD
Etoposide—ABCC1—Disease—ERBB2—esophageal cancer	2.34e-06	4.72e-05	CbGpPWpGaD
Etoposide—CYP3A4—Metabolism—ADH1B—esophageal cancer	2.33e-06	4.7e-05	CbGpPWpGaD
Etoposide—CYP2C8—Metabolism—CYP1B1—esophageal cancer	2.32e-06	4.68e-05	CbGpPWpGaD
Etoposide—CYP2E1—Metabolism—HMOX1—esophageal cancer	2.3e-06	4.65e-05	CbGpPWpGaD
Etoposide—CYP3A5—Metabolism—HMOX1—esophageal cancer	2.29e-06	4.64e-05	CbGpPWpGaD
Etoposide—PTGS2—Disease—HIF1A—esophageal cancer	2.29e-06	4.63e-05	CbGpPWpGaD
Etoposide—ABCC1—Disease—PTGS2—esophageal cancer	2.28e-06	4.61e-05	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism—GNG7—esophageal cancer	2.27e-06	4.58e-05	CbGpPWpGaD
Etoposide—PTGS1—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	2.23e-06	4.51e-05	CbGpPWpGaD
Etoposide—CYP3A4—Metabolism—TYMP—esophageal cancer	2.23e-06	4.5e-05	CbGpPWpGaD
Etoposide—CYP2E1—Metabolism—ABCB1—esophageal cancer	2.21e-06	4.46e-05	CbGpPWpGaD
Etoposide—CYP3A5—Metabolism—ABCB1—esophageal cancer	2.2e-06	4.45e-05	CbGpPWpGaD
Etoposide—CYP2C8—Metabolism—CYP19A1—esophageal cancer	2.18e-06	4.4e-05	CbGpPWpGaD
Etoposide—UGT1A1—Metabolism—NOS3—esophageal cancer	2.17e-06	4.38e-05	CbGpPWpGaD
Etoposide—CYP3A4—Metabolism—CYP26A1—esophageal cancer	2.17e-06	4.37e-05	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism—ALDH2—esophageal cancer	2.13e-06	4.29e-05	CbGpPWpGaD
Etoposide—CYP3A4—Metabolism—ALOX15—esophageal cancer	2.11e-06	4.26e-05	CbGpPWpGaD
Etoposide—ABCC1—Metabolism—NOS3—esophageal cancer	2.09e-06	4.22e-05	CbGpPWpGaD
Etoposide—PTGS2—Disease—NOS2—esophageal cancer	2.08e-06	4.21e-05	CbGpPWpGaD
Etoposide—PTGS2—Disease—NOTCH1—esophageal cancer	2.06e-06	4.17e-05	CbGpPWpGaD
Etoposide—ABCG2—Metabolism—CREBBP—esophageal cancer	2.05e-06	4.15e-05	CbGpPWpGaD
Etoposide—ABCC3—Metabolism—EP300—esophageal cancer	2.03e-06	4.1e-05	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism—GSTT1—esophageal cancer	2.02e-06	4.08e-05	CbGpPWpGaD
Etoposide—ABCB1—Metabolism—CYP1B1—esophageal cancer	2.02e-06	4.08e-05	CbGpPWpGaD
Etoposide—CYP3A4—Metabolism—TPI1—esophageal cancer	2.01e-06	4.07e-05	CbGpPWpGaD
Etoposide—CYP3A4—Metabolism—GSTO1—esophageal cancer	2.01e-06	4.07e-05	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism—CYP2A6—esophageal cancer	2e-06	4.04e-05	CbGpPWpGaD
Etoposide—ABCC1—Disease—CDKN1A—esophageal cancer	2e-06	4.03e-05	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism of lipids and lipoproteins—CREBBP—esophageal cancer	1.99e-06	4.02e-05	CbGpPWpGaD
Etoposide—CYP2C8—Metabolism—HMOX1—esophageal cancer	1.99e-06	4.02e-05	CbGpPWpGaD
Etoposide—UGT1A1—Metabolism—PTGS2—esophageal cancer	1.98e-06	4.01e-05	CbGpPWpGaD
Etoposide—PTGS1—Metabolism—CREBBP—esophageal cancer	1.97e-06	3.99e-05	CbGpPWpGaD
Etoposide—CYP2C8—Metabolism of lipids and lipoproteins—EP300—esophageal cancer	1.95e-06	3.94e-05	CbGpPWpGaD
Etoposide—CYP3A4—Metabolism—ALDOB—esophageal cancer	1.93e-06	3.9e-05	CbGpPWpGaD
Etoposide—ABCC1—Metabolism—PTGS2—esophageal cancer	1.91e-06	3.86e-05	CbGpPWpGaD
Etoposide—CYP2C8—Metabolism—ABCB1—esophageal cancer	1.91e-06	3.85e-05	CbGpPWpGaD
Etoposide—ABCC1—Disease—EP300—esophageal cancer	1.9e-06	3.84e-05	CbGpPWpGaD
Etoposide—ABCB1—Metabolism—CYP19A1—esophageal cancer	1.9e-06	3.83e-05	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism—ENO1—esophageal cancer	1.9e-06	3.83e-05	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism—PTGS1—esophageal cancer	1.9e-06	3.83e-05	CbGpPWpGaD
Etoposide—PTGS2—Disease—CREBBP—esophageal cancer	1.87e-06	3.78e-05	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism—PSME2—esophageal cancer	1.87e-06	3.77e-05	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism—PSME1—esophageal cancer	1.87e-06	3.77e-05	CbGpPWpGaD
Etoposide—CYP3A4—Metabolism—GAPDH—esophageal cancer	1.86e-06	3.75e-05	CbGpPWpGaD
Etoposide—CYP3A4—Metabolism—CRABP1—esophageal cancer	1.84e-06	3.72e-05	CbGpPWpGaD
Etoposide—ABCG2—Metabolism—NOS3—esophageal cancer	1.84e-06	3.72e-05	CbGpPWpGaD
Etoposide—PTGS2—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	1.77e-06	3.58e-05	CbGpPWpGaD
Etoposide—PTGS1—Metabolism—NOS3—esophageal cancer	1.77e-06	3.57e-05	CbGpPWpGaD
Etoposide—CYP3A4—Metabolism—GNG7—esophageal cancer	1.75e-06	3.54e-05	CbGpPWpGaD
Etoposide—ABCB1—Metabolism—HMOX1—esophageal cancer	1.73e-06	3.5e-05	CbGpPWpGaD
Etoposide—ABCG2—Metabolism—PTGS2—esophageal cancer	1.68e-06	3.4e-05	CbGpPWpGaD
Etoposide—PTGS2—Disease—NOS3—esophageal cancer	1.68e-06	3.38e-05	CbGpPWpGaD
Etoposide—ABCC1—Disease—MYC—esophageal cancer	1.65e-06	3.34e-05	CbGpPWpGaD
Etoposide—UGT1A1—Metabolism—EP300—esophageal cancer	1.65e-06	3.33e-05	CbGpPWpGaD
Etoposide—CYP3A4—Metabolism—ALDH2—esophageal cancer	1.64e-06	3.31e-05	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—esophageal cancer	1.63e-06	3.29e-05	CbGpPWpGaD
Etoposide—ABCC1—Disease—EGFR—esophageal cancer	1.62e-06	3.27e-05	CbGpPWpGaD
Etoposide—PTGS1—Metabolism—PTGS2—esophageal cancer	1.62e-06	3.27e-05	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism—CYP1B1—esophageal cancer	1.61e-06	3.25e-05	CbGpPWpGaD
Etoposide—ABCC1—Metabolism—EP300—esophageal cancer	1.59e-06	3.21e-05	CbGpPWpGaD
Etoposide—PTGS2—Metabolism—CREBBP—esophageal cancer	1.57e-06	3.17e-05	CbGpPWpGaD
Etoposide—PTGS2—Disease—ERBB2—esophageal cancer	1.57e-06	3.17e-05	CbGpPWpGaD
Etoposide—CYP3A4—Metabolism—GSTT1—esophageal cancer	1.56e-06	3.15e-05	CbGpPWpGaD
Etoposide—CYP3A4—Metabolism—CYP2A6—esophageal cancer	1.54e-06	3.12e-05	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism—CYP19A1—esophageal cancer	1.51e-06	3.06e-05	CbGpPWpGaD
Etoposide—ABCC3—Metabolism—PIK3CA—esophageal cancer	1.5e-06	3.03e-05	CbGpPWpGaD
Etoposide—CYP2E1—Metabolism—CREBBP—esophageal cancer	1.48e-06	2.98e-05	CbGpPWpGaD
Etoposide—CYP3A5—Metabolism—CREBBP—esophageal cancer	1.47e-06	2.97e-05	CbGpPWpGaD
Etoposide—CYP3A4—Metabolism—ENO1—esophageal cancer	1.46e-06	2.95e-05	CbGpPWpGaD
Etoposide—CYP3A4—Metabolism—PTGS1—esophageal cancer	1.46e-06	2.95e-05	CbGpPWpGaD
Etoposide—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	1.44e-06	2.91e-05	CbGpPWpGaD
Etoposide—CYP3A4—Metabolism—PSME2—esophageal cancer	1.44e-06	2.91e-05	CbGpPWpGaD
Etoposide—CYP3A4—Metabolism—PSME1—esophageal cancer	1.44e-06	2.91e-05	CbGpPWpGaD
Etoposide—ABCC1—Disease—PIK3CA—esophageal cancer	1.4e-06	2.84e-05	CbGpPWpGaD
Etoposide—PTGS2—Metabolism—NOS3—esophageal cancer	1.4e-06	2.83e-05	CbGpPWpGaD
Etoposide—ABCG2—Metabolism—EP300—esophageal cancer	1.4e-06	2.83e-05	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism—HMOX1—esophageal cancer	1.38e-06	2.79e-05	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism of lipids and lipoproteins—EP300—esophageal cancer	1.36e-06	2.74e-05	CbGpPWpGaD
Etoposide—PTGS1—Metabolism—EP300—esophageal cancer	1.34e-06	2.72e-05	CbGpPWpGaD
Etoposide—PTGS2—Disease—CDKN1A—esophageal cancer	1.34e-06	2.71e-05	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism—ABCB1—esophageal cancer	1.33e-06	2.68e-05	CbGpPWpGaD
Etoposide—CYP2E1—Metabolism—NOS3—esophageal cancer	1.32e-06	2.67e-05	CbGpPWpGaD
Etoposide—CYP3A5—Metabolism—NOS3—esophageal cancer	1.32e-06	2.66e-05	CbGpPWpGaD
Etoposide—CYP2C8—Metabolism—CREBBP—esophageal cancer	1.28e-06	2.58e-05	CbGpPWpGaD
Etoposide—PTGS2—Disease—EP300—esophageal cancer	1.27e-06	2.57e-05	CbGpPWpGaD
Etoposide—CYP3A4—Metabolism—CYP1B1—esophageal cancer	1.24e-06	2.51e-05	CbGpPWpGaD
Etoposide—UGT1A1—Metabolism—PIK3CA—esophageal cancer	1.22e-06	2.46e-05	CbGpPWpGaD
Etoposide—CYP2E1—Metabolism—PTGS2—esophageal cancer	1.21e-06	2.44e-05	CbGpPWpGaD
Etoposide—CYP3A5—Metabolism—PTGS2—esophageal cancer	1.21e-06	2.44e-05	CbGpPWpGaD
Etoposide—ABCC1—Metabolism—PIK3CA—esophageal cancer	1.18e-06	2.38e-05	CbGpPWpGaD
Etoposide—CYP3A4—Metabolism—CYP19A1—esophageal cancer	1.17e-06	2.36e-05	CbGpPWpGaD
Etoposide—CYP2C8—Metabolism—NOS3—esophageal cancer	1.14e-06	2.31e-05	CbGpPWpGaD
Etoposide—ABCB1—Metabolism—CREBBP—esophageal cancer	1.11e-06	2.24e-05	CbGpPWpGaD
Etoposide—PTGS2—Disease—MYC—esophageal cancer	1.11e-06	2.24e-05	CbGpPWpGaD
Etoposide—PTGS2—Disease—EGFR—esophageal cancer	1.09e-06	2.19e-05	CbGpPWpGaD
Etoposide—PTGS2—Metabolism—EP300—esophageal cancer	1.07e-06	2.16e-05	CbGpPWpGaD
Etoposide—CYP3A4—Metabolism—HMOX1—esophageal cancer	1.07e-06	2.16e-05	CbGpPWpGaD
Etoposide—CYP2C8—Metabolism—PTGS2—esophageal cancer	1.04e-06	2.11e-05	CbGpPWpGaD
Etoposide—ABCG2—Metabolism—PIK3CA—esophageal cancer	1.04e-06	2.09e-05	CbGpPWpGaD
Etoposide—CYP3A4—Metabolism—ABCB1—esophageal cancer	1.02e-06	2.07e-05	CbGpPWpGaD
Etoposide—CYP2E1—Metabolism—EP300—esophageal cancer	1e-06	2.03e-05	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	1e-06	2.03e-05	CbGpPWpGaD
Etoposide—CYP3A5—Metabolism—EP300—esophageal cancer	1e-06	2.03e-05	CbGpPWpGaD
Etoposide—ABCB1—Metabolism—NOS3—esophageal cancer	9.95e-07	2.01e-05	CbGpPWpGaD
Etoposide—PTGS1—Metabolism—PIK3CA—esophageal cancer	9.95e-07	2.01e-05	CbGpPWpGaD
Etoposide—PTGS2—Disease—PIK3CA—esophageal cancer	9.43e-07	1.9e-05	CbGpPWpGaD
Etoposide—ABCB1—Metabolism—PTGS2—esophageal cancer	9.1e-07	1.84e-05	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism—CREBBP—esophageal cancer	8.87e-07	1.79e-05	CbGpPWpGaD
Etoposide—CYP2C8—Metabolism—EP300—esophageal cancer	8.68e-07	1.75e-05	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism—NOS3—esophageal cancer	7.94e-07	1.6e-05	CbGpPWpGaD
Etoposide—PTGS2—Metabolism—PIK3CA—esophageal cancer	7.9e-07	1.59e-05	CbGpPWpGaD
Etoposide—ABCB1—Metabolism—EP300—esophageal cancer	7.57e-07	1.53e-05	CbGpPWpGaD
Etoposide—CYP2E1—Metabolism—PIK3CA—esophageal cancer	7.43e-07	1.5e-05	CbGpPWpGaD
Etoposide—CYP3A5—Metabolism—PIK3CA—esophageal cancer	7.42e-07	1.5e-05	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism—PTGS2—esophageal cancer	7.26e-07	1.47e-05	CbGpPWpGaD
Etoposide—CYP3A4—Metabolism—CREBBP—esophageal cancer	6.84e-07	1.38e-05	CbGpPWpGaD
Etoposide—CYP2C8—Metabolism—PIK3CA—esophageal cancer	6.42e-07	1.3e-05	CbGpPWpGaD
Etoposide—CYP3A4—Metabolism—NOS3—esophageal cancer	6.13e-07	1.24e-05	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism—EP300—esophageal cancer	6.04e-07	1.22e-05	CbGpPWpGaD
Etoposide—CYP3A4—Metabolism—PTGS2—esophageal cancer	5.6e-07	1.13e-05	CbGpPWpGaD
Etoposide—ABCB1—Metabolism—PIK3CA—esophageal cancer	5.6e-07	1.13e-05	CbGpPWpGaD
Etoposide—CYP3A4—Metabolism—EP300—esophageal cancer	4.66e-07	9.42e-06	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism—PIK3CA—esophageal cancer	4.47e-07	9.02e-06	CbGpPWpGaD
Etoposide—CYP3A4—Metabolism—PIK3CA—esophageal cancer	3.45e-07	6.97e-06	CbGpPWpGaD
